Extramedullary plasmacytomas are uncommon tumors, with a worldwide annual incidence of 3 per 100,000 population. They accountfor 1% ofall tumors ofthe head and neck and 4% ofall nonepithelial tumors ofthe nasal tract. A variety of treatment options has been suggested. These treatments VQl Y according to the site ofpresentation, the presence of locoregional spread, and the histologic picture . Radiotherapy has been widely used as a treatment modality, but little has been written about surgery as a single management modality. However, such an option assumes importance in a developing nation, where patient follow-up is errati c and treatment costs must be kept low. We discuss the feasibility of surgery in such a circumstance, and we describe our surgical treatment of a case of extramedullary plasmacytoma in an elderly woman who presented to our hosp ital in India.
Introduction
Aplasma cell neoplasm represents a monoclonal proliferation of a B cell that has undergone (potentially malignant) transformation into a plasmacytoid cell. The three types of plasma cell neoplasms are multiple myeloma, medullary plasmacytoma , and extramedullary plasmacytoma. Extramedullary plasmacytomas occur in soft tissue outside the medullary bone-hence their name . Because of their rarity, they pose a diagnostic and treatment challenge to ENT surgeons. Treatment of multiple myelomas and medullary plasmacytomas is fairly standard, but such is not the case for extramedullary plasmacytomas.
We describe a case of nasal extramedullary plasmacytoma that posed a dilemma in that it featured a number of treatment-limiting factors . These limitations compelled 
Case report
A 75-year-old woman presented with a 6-month history of right-s ided nasal obstruction, a nasal mass , and blood-stained nasal disch arge . Examination revealed that a gray-white mass with surface ulceration had filled the entire nasal vestibule. The probe test suggested that the mass was attached to the lateral nasal wall. Findings on posterior rhinoscopy were normal. Computed tomography (CT) showed that the 5 x 4-cm heterogenous mass had originated in the lateral nasal wall ; the septum was tumor-free (figure I). Punch biopsy identified the mass as a plasmacytoma. An undifferentiated carcinoma had been suspected initially, but it was ruled out by immunohistochemistry. Evaluation of other muco sal surfaces of the upper aerodigestive tract detected no other significant masses . No cervical lymphadenopathy was present. A systemic workup for multiple myeloma included a bone marrow biopsy, bone scan , quantitative immunoglobulin assay, and measurements of hematocrit, white blood cells, blood urea, serum creatinine, serum electrolytes, serum calcium, and BenceJones proteins in urine. All findings were within norm al limits . Hence, a diagnosis of a solitary extramedullary plasmacytoma was established.
The patient's logistical and financial circum stances precluded radiotherapy, and we therefore performed a medial maxillectomy with adequate excision of the tumor margins. Operative findings showed that the tumor had arisen from the middle turbinate. Blood loss during the procedure was minimal , and the patient did not require any transfusion. Her postoperative course was uneventful, and she was discharged on postoperative day 6.
Grossly, the tumor was a gray-white nodular mass that measured 5 x 4 x 1.5 em . A cut-surface analysis revealed that it was pale brown with foci of congestion. Microscopically, the mass was made up of monotonous sheets of neoplastic plasma cells with eccentric hyperchromatic 
Discussion
Approximately 80% of extramedullary plasmacytomas occur in the head and neck; of these , a similar percentage present in the upper aerodigestive tract and oral cavity.1.2 In this area, most occur in the nose, paranasal sinuses , and nasopharynx (78% of cases).' > These tumor s are three to four times more common in males than in females .I Soft-tissue plasmacytomas arise from plasma cell s located on the mucosal surfaces. They account for 3% of all plasma cell neoplasms .'
In 1976, Wiltshaw' described a staging system for extramedullary plasmacytomas:
A nuclei and irregular chromatin distribution ( figure 2, A) . A second immunohistochemical stain confirmed that the lesion was not a carcinoma ( figure 2, B ). Binucleation and multinucleation were present. Microscopy confirmed that all resection margins, including the underlying bone and marrow, were free of tumor.
When last seen 3 years postoperatively, the patient exhibited no signs or symptoms of recurrence or progression to multiple myeloma.
• Stage I disease is defined by the presence of a tumor at only one extramedullary site. • Stage II disease indicates involvement ofregional lymph nodes. • Stage III disease involves multiple metastases-in which case, the patient by definition no longer has solitary plasmacytoma.
The case described in this article posed a diagno stic dilemma. The physical appearance of the tumor-including B Figure 2 
. A: Photomicrograph shows the sheets ofplasma cells (H&E, original magnification x lO). B: Postoperati ve immunohistochemistry shows cytokeratin negativity (oil immersion, original magnification x 100). in set: Binucleated plasma cells are visible (H&E, original magnification x 40).
Volume 85, Number 7 GROVER, CHARY, MAKHIJA , ROUT the surface ulcer ation , which is rarely seen in plasmacytomas-was characteristic of a malignancy, which is usually the diagnosis for tumors at this site." It was only upon histopathologic examination and immunohistochemistry that we clinched the diagnosis.
Because most patients who present with extramedull ary plasmac ytoma are elderly and because it has been suggested that this rare tumo r be treated as a malignancy ," various treatment mod alitie s in various combinations have been tried. The choic e of treatment is also influenced by the extent of the tumor. Surgery is recommended for lesions that are localized and can be excised without much morbidity. Endoscopic excision, laser excision, and excision biop sy have been described for nasal and cervical lesions ; these procedures are usually combined with adj unctive radiotherapy, which may either precede or follow surgery." One argument against aggressive management is the fact that local control is excellent regardless of tumor size; only 6 to 10% of patients experience a recurrence after adequate initi al treatment.' Moreover, becau se most of these tumors in the head and neck are in the vicinity of vital structures, extensive surgery for removal of large tumors with adequate margins would be disfiguring. Therefore, radiotherapy is considered by many the treatment of choice for this radiosensitive tumor."
In choosing the treatment strategy for our patient, we had to consider several factors. She lived in rural India, far from the hospital, and she was of low socioeconomic status . A 50-Gy course of radiotherapy at 2 Gy/d ay would have requ ired 5 consecutive weeks of treatment and a prolonged hospital stay; the cost of this option was unacceptable to her. Also , the chance that she would be able to comply with a postr adiation outpatient follow-up schedule was low.
Endoscopic clearance as a single-modality treatment was ruled out because it would have been very difficult to achieve adequate (1.5 em) margins and because it is more effective when combined with radiotherapy.V And again, regular endoscopic follow-up examinations would have been necessary to look for any recurrence.
Surgery was the only feasible option, and we decided to perform a medial maxillectomy with compl ete excision of the tumor. Surgical morbidity was minimal , and the patient was discharged within a week. Wound healin g was good, and the patient experienced no procedure-related complications. The cost of this treatment was approximately one-half that of radi otherapy, with one-fifth the number of hospitalization days. Because spread to regional lymph nodes is not very common, OCCUlTing in 15to 20% of cases , we did not admini ster any treatment to the neck.?
There is some controversy in the literature over whether extramedulla ry plasmacytoma represents an early, localized stage of multiple myeloma or if it is a distinct entity. The former view may hold for solitary pla smacytom as of bone, 436 as 85% of such patients progress to multipl e myeloma.' However, only 15 to 20% of patients with extramedullary plasmacytom as progre ss to multipl e myelom a or develop regional disease.' A rise in baseline level s of serum myeloma monoclonal proteins or urine Bence Jone s protein may signify a recurrence of the primary or the onset of multiple myeloma.' Therefore, long-term follow-up for locoregi onal control and to look for progression to multiple myeloma is necessary.
In conclu sion, it is our opinion that medi al maxillectomy in appropriately selected patient s with extram edullary plasmacytom a of the lateral nasal wall is an accept able treatment. It has significant advantages over radiotherapy in terms of morbidity and cost.
